VICTORY CAPITAL MANAGEMENT INC

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1040188 San Antonio, TX

Position in RYTM

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$852,599

-$930,633 QoQ

Shares Held

7,679

-62.5% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#167

of 299 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. RYTM ranks #79 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,173,152	$1,079,469,792
2	RPRX	Royalty Pharma plc	3,682,932	$206,501,997
3	INCY	Incyte Corp	1,480,342	$167,811,569
4	JAZZ	Jazz Pharmaceuticals plc	686,719	$165,478,677
5	LGND	Ligand Pharmaceuticals Inc	253,764	$80,212,262
6	REGN	Regeneron Pharmaceuticals, Inc.	126,343	$78,779,914
7	ALNY	Alnylam Pharmaceuticals, Inc.	172,842	$52,030,627
8	BNTX	BioNTech SE	539,787	$50,227,180

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$852,599	7,679	-62.5%	Shares	Sole	2026-08-07
2026-03-31	$1,783,232	20,504	-54.8%	Shares	Sole	2026-05-15
2025-12-31	$4,857,582	45,381	+5.8%	Shares	Sole	2026-02-13
2025-09-30	$4,330,754	42,883	+164.0%	Shares	Sole	2025-11-12
2025-06-30	$1,026,268	16,241	-6.3%	Shares	Sole	2025-08-13
2025-03-31	$917,758	17,326	+1.0%	Shares	Sole	2025-05-02
2024-12-31	$960,168	17,152	-5.7%	Shares	Sole	2025-02-06
2024-09-30	$952,764	18,186	+158.0%	Shares	Sole	2024-11-05
2024-06-30	$289,431	7,049	-53.3%	Shares	Sole	2024-08-05
2024-03-31	$653,633	15,085	-91.7%	Shares	Sole	2024-05-03
2023-12-31	$8,380,193	182,297	+809.2%	Shares	Sole	2024-02-05
2023-09-30	$459,646	20,050	+369.1%	Shares	Sole	2023-11-06
2020-03-31	$65,050	4,274	—	Shares	Sole	2020-05-04
No filing history on record for this holder in this stock.